Gotham Asset Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1510387
NEW YORK, NY
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,658,612
-$1,803,715 QoQ
Shares Held
42,051
-3.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#165
of 784 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. ALNY ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
719,545 | $81,567,621 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,165 | $65,574,584 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
739,273 | $57,862,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
892,663 | $48,569,793 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,349,465 | $47,757,566 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
112,014 | $26,992,013 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
120,702 | $22,605,070 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
42,051 | $12,658,612 |
All Filings in ALNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,658,612 | 42,051 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,462,327 | 43,710 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,755,688 | 39,622 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,829,560 | 28,135 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,800,162 | 17,787 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,919,880 | 14,517 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,570,526 | 10,924 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,833,652 | 17,575 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,216,591 | 13,237 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $305,924 | 2,047 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,068,950 | 10,809 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $545,822 | 3,082 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $732,598 | 3,857 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,024,837 | 5,116 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $804,682 | 3,386 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $677,141 | 3,383 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $453,010 | 3,106 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $211,950 | 1,298 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $485,906 | 4,464 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||